These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27866277)

  • 81. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
    Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U
    Respiration; 2017; 93(6):415-423. PubMed ID: 28399537
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
    Marchioni A; Tonelli R; Ball L; Fantini R; Castaniere I; Cerri S; Luppi F; Malerba M; Pelosi P; Clini E
    Crit Care; 2018 Mar; 22(1):80. PubMed ID: 29566734
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lung transplant in idiopathic pulmonary fibrosis.
    George TJ; Arnaoutakis GJ; Shah AS
    Arch Surg; 2011 Oct; 146(10):1204-9. PubMed ID: 22006881
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [
    Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
    Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Health-related quality of life in idiopathic pulmonary fibrosis: where are we now?
    Belkin A; Swigris JJ
    Curr Opin Pulm Med; 2013 Sep; 19(5):474-9. PubMed ID: 23851327
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immune dysregulation as a driver of idiopathic pulmonary fibrosis.
    Shenderov K; Collins SL; Powell JD; Horton MR
    J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33463535
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Idiopathic pulmonary fibrosis: a more common condition than you may think.
    Tremayne P; John Clark S
    Br J Nurs; 2021 Mar; 30(6):359-366. PubMed ID: 33769879
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada.
    Tarride JE; Hopkins RB; Burke N; Guertin JR; O'Reilly D; Fell CD; Dion G; Kolb M
    Clinicoecon Outcomes Res; 2018; 10():127-137. PubMed ID: 29503576
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The need for patient-centred clinical research in idiopathic pulmonary fibrosis.
    Russell AM; Sprangers MA; Wibberley S; Snell N; Rose DM; Swigris JJ
    BMC Med; 2015 Sep; 13():240. PubMed ID: 26399318
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A systematic review of literature to evaluate the burden of physical and psychological symptoms and palliative care in patients diagnosed with idiopathic pulmonary fibrosis.
    van Jaarsveld MF; Gwyther L
    Afr J Thorac Crit Care Med; 2019; 25(1):. PubMed ID: 34286243
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Care programs and their components for patients with idiopathic pulmonary fibrosis: a systematic review.
    Delameillieure A; Vandekerkhof S; Van Grootven B; Wuyts WA; Dobbels F
    Respir Res; 2021 Aug; 22(1):229. PubMed ID: 34399748
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A cross-sectional evaluation of the idiopathic pulmonary fibrosis patient satisfaction and quality of life with a care coordinator.
    Hambly N; Goodwin S; Aziz-Ur-Rehman A; Makhdami N; Ainslie-Garcia M; Grima D; Cox G; Kolb M; Fung D; Cabalteja C; DeMarco P; Moldaver D
    J Thorac Dis; 2019 Dec; 11(12):5547-5556. PubMed ID: 32030274
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tackling the Neuropathic Cough of Idiopathic Pulmonary Fibrosis (IPF): More Needs to be Done.
    Chung KF; Birring SS; Morice AH; McGarvey LP; Mazzone SB; Maher TM; Dicpinigaitis PV
    Lung; 2022 Dec; 200(6):673-675. PubMed ID: 36348052
    [No Abstract]   [Full Text] [Related]  

  • 95. Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis.
    Moor CC; Heukels P; Kool M; Wijsenbeek MS
    Front Med (Lausanne); 2017; 4():226. PubMed ID: 29326935
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Understanding the informational needs of patients with IPF and their caregivers: 'You get diagnosed, and you ask this question right away, what does this mean?'.
    Ramadurai D; Corder S; Churney T; Graney B; Harshman A; Meadows S; Swigris JJ
    BMJ Open Qual; 2018; 7(1):e000207. PubMed ID: 29464212
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Economic consequences of idiopathic pulmonary fibrosis in Denmark.
    Hilberg O; Bendstrup E; Ibsen R; Løkke A; Hyldgaard C
    ERJ Open Res; 2018 Apr; 4(2):. PubMed ID: 29850467
    [No Abstract]   [Full Text] [Related]  

  • 98. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis.
    Nathan SD; Albera C; Bradford WZ; Costabel U; Glaspole I; Glassberg MK; Kardatzke DR; Daigl M; Kirchgaessler KU; Lancaster LH; Lederer DJ; Pereira CA; Swigris JJ; Valeyre D; Noble PW
    Lancet Respir Med; 2017 Jan; 5(1):33-41. PubMed ID: 27876247
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Skewed Lung CCR4 to CCR6 CD4
    Adegunsoye A; Hrusch CL; Bonham CA; Jaffery MR; Blaine KM; Sullivan M; Churpek MM; Strek ME; Noth I; Sperling AI
    Front Immunol; 2016; 7():516. PubMed ID: 27933058
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Idiopathic pulmonary fibrosis: Are any of the morphological-molecular markers useful in clinical management?
    Lunardi F; Balestro E; Nannini N; Vuljan SE; Rea F; Calabrese F
    Histol Histopathol; 2017 Jul; 32(7):661-672. PubMed ID: 27910075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.